Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Bi-weekly Taxol and Definitive Radiation in Androgen Ablated Locally Advanced Prostate Cancer

NCT02911350 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02911350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Bi-weekly Taxol and Definitive Radiation in Androgen Ablated Locally Advanced Prostate Cancer
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2000
Completion date
December 31, 2016
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer